|

Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents

RECRUITINGSponsored by Jordan Collaborating Cardiology Group
Actively Recruiting
SponsorJordan Collaborating Cardiology Group
Started2025-08-01
Est. completion2026-08-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07039149

Summary

This is a chart review of data on use of antiplatelet (AP) medications for acute coronary syndrome in the ER. Guidelines recommend giving aspirin in the ER and a second AP agent in the cath lab. What is the outcome when the 2 agents are given n the ER?

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adult patients
* Presenting with acute coronary syndrome (ST segment elevation myocardial infarction, non ST segment elevation myocardial infarction, and unstable angina).
* Antiplatelet medication (s) prescribed during index admission to hospital.
* Willingness of the patient to be called for follow up up to 1 year after index hospitalization.

Exclusion Criteria:

* Non cardiac chest pain.
* No administration of antiplatelet agents during hospitalization.
* Refusal of contact for follow up.

Conditions3

Heart DiseaseMajor Adverse Cardiovascular and Cerebrovascular Events (MACCE)Major Bleeding

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.